Interviews - Page 14 of 21 - Express Pharma

Our digital-funding-network will support India pharma’s next phase of super-growth

Post-COVID, there will be a mix of various working models

Hilleman Labs is developing a liquid form of meningococcal vaccine in a single container closure

In the pharma industry, technology has become a mandate for some compliances

We have found multiple molecules that could be effective against coronavirus

How the AMR Action Fund intends to support antibiotic-focused biotechs

Over one in five life sciences companies have launched a digital initiative to enhance customer experience

COVID-19 crisis has spawned new avenues of doing business for pharma

The rise in talent demand will be for specialist functions like R&D, trials and approvals

Genetics has revolutionised patient selection for clinical trials